$8.01
0.25% yesterday
Nasdaq, May 20, 08:45 pm CET
ISIN
US86889P1093
Symbol
SRZN

Surrozen Inc Stock price

$8.47
-1.13 11.77% 1M
-0.43 4.83% 6M
-5.88 40.98% YTD
-0.99 10.47% 1Y
-28.73 77.23% 3Y
-143.18 94.41% 5Y
-143.18 94.41% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.44 5.48%
ISIN
US86889P1093
Symbol
SRZN
Sector

Key metrics

Market capitalization $72.52m
Enterprise Value $-21.16m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 1.16
EV/Sales (TTM) EV/Sales -1.82
P/S ratio (TTM) P/S ratio 6.23
P/B ratio (TTM) P/B ratio 12.68
Revenue (TTM) Revenue $11.64m
EBIT (operating result TTM) EBIT $-25.96m
Free Cash Flow (TTM) Free Cash Flow $-18.21m
Cash position $101.65m
EPS (TTM) EPS $-24.46
P/E forward negative
P/S forward 145.04
EV/Sales forward negative
Short interest 0.67%
Show more

Is Surrozen Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Surrozen Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Surrozen Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Surrozen Inc forecast:

Buy
100%

Financial data from Surrozen Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
12 12
-
100%
- Direct Costs 1.34 1.34
37% 37%
12%
10 10
583% 583%
88%
- Selling and Administrative Expenses 14 14
13% 13%
119%
- Research and Development Expense 21 21
5% 5%
181%
-25 -25
33% 33%
-212%
- Depreciation and Amortization 1.34 1.34
37% 37%
12%
EBIT (Operating Income) EBIT -26 -26
33% 33%
-223%
Net Profit -82 -82
117% 117%
-702%

In millions USD.

Don't miss a Thing! We will send you all news about Surrozen Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surrozen Inc Stock News

Neutral
GlobeNewsWire
7 days ago
Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -incorporating novel discoveries related to requirements for efficient and selective Wnt pathway signaling SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the ...
Neutral
GlobeNewsWire
11 days ago
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a focus on severe eye diseases, today announced financial results for the first quarter ended March 31, 2025, and provided a business ...
Negative
24/7 Wall Street
about 2 months ago
After struggling through a rough patch, the biotech industry seems to be staging a comeback.
More Surrozen Inc News

Company Profile

Surrozen, Inc. is a preclinical stage biotechnology company, which engages in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. It is also focused on developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye diseases, hearing loss, lung and airway diseases, and certain neurological disorders. The company was founded on August 12, 2015 and is headquartered in South San Francisco, CA.

Head office United States
CEO Craig Parker
Employees 41
Founded 2015
Website www.surrozen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today